GLP-1 Agonists May Help Treatment of Mental Illness and Substance Use

Last week, Vermont Senator Bernie Sanders pressed the chief executive officer of Novo Nordisk to lower prices of popular weight-loss drugs such as semaglutide – marketed in the United States as Wegovy and Ozempic.